Brensocatib for treating moderate to severe non-cystic fibrosis bronchiectasis in people 12 years and over ID 6448Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Elexacaftor–tezacaftor–ivacaftor with ivacaftor for treating cystic fibrosis without an F508del mutation and with a mutation in the CFTR gene that is responsive to elexacaftor–tezacaftor–ivacaftor in people aged 6 and over TS ID 11847Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC